Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog

Journal of Veterinary Pharmacology and Therapeutics

Volumn 33, Issue 2, 2010, Pages 118-131

  Schmid, V B ^a   Spreng, D E ^b   Seewald, W ^c   Jung, M ^a   Lees, P ^d   King, J N ^c  

^a Centre de Recherche Sante Animale   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ROBENACOXIB; UNCLASSIFIED DRUG; URATE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTHRALGIA; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; EX VIVO STUDY; FEMALE; JOINT SWELLING; MALE; NONHUMAN; PRIORITY JOURNAL; SYNOVITIS; TIME TO MAXIMUM PLASMA CONCENTRATION; WEIGHT BEARING;

CANIS FAMILIARIS;

EID: 77949413377     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2009.01117.x     Document Type: Article

References (43)

1. Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M.B., Hawkey, C.J., Hochberg, M.C., Kvien, T.K., Schnitzer, T.J. for the VIGOR study group. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. The New England Journal of Medicine, 343, 1520-1528.
2. Borer, L.R., Peel, J.E., Seewald, W., Schawalder, P. & Spreng, D.E. (2003) Effect of carprofen, etodolac, meloxicam, or butorphanol in dogs with induced acute synovitis. American Journal of Veterinary Research, 64, 1429-1437.
3. Brideau, C., Van Staden, C. & Chan, C.C. (2001) In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs and cats. American Journal of Veterinary Research, 62, 1755-1760.
4. Brune, K. & Furst, D.E. (2007) Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?. Rheumatology, 46, 911-919.
5. Cross, A.R., Budsberg, S.C. & Keefe, T.J. (1997) Kinetic gait analysis assessment of meloxicam efficacy in a sodium uric acid-induced synovitis model in dogs. American Journal of Veterinary Research, 58, 626-631.
6. Drag, M., Kunkle, B.N., Romano, D. & Hanson, P.D. (2007) Firocoxib efficacy preventing urate-induced synovitis, pain and inflammation in dogs. Veterinary Therapeutics: Research in Applied Veterinary Medicine, 8, 41-50.
7. Fam, A.G. & Schumacher, H.R. (1987) Crystal-induced joint inflammation. In: Greenwald, R.A., Diamond, H.S., eds. Handbook of Animal Models for the Rheumatic Diseases. Vol 2. Boca Raton, Fla: CRC Press Inc.: 2, 99-125.
8. Flower, R.J. (2003) The development of COX-2 inhibitors. Nature Reviews Drug Discovery, 2, 179-191.
9. Gierse, J.K., Staten, N.R., Casperson, G.F., Koboldt, C.M., Trigg, J.S., Reitz, B.A., Pierce, J.L. & Seibert, K. (2002) Cloning expression and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2. Veterinary Therapeutics: research in applied veterinary medicine, 3, 270-280.
10. Giraudel, J.M., Toutain, P.L. & Lees, P. (2005a) Development of in vitro assays for the evaluation of cyclooxygenase inhibitors and application for predicting the selectivity of NSAIDs in the cat. American Journal of Veterinary Research, 66, 700-709.
11. Giraudel, J.M., Diquelou, A., Laroute, V., Lees, P. & Toutain, P.L. (2005b) Pharmacokinetic/pharmacodynamic modelling of NSAIDs in a model of reversible inflammation in the cat. British Journal of Pharmacology, 146, 642-653.
12. Giraudel, J.M., Toutain, P.L., King, J.N. & Lees, P. (2009a) Differential inhibition of cyclooxygenase isoenzymes in the cat by the NSAID robenacoxib. Journal of Veterinary Pharmacology and Therapeutics, 32, 31-40.
13. Giraudel, J.M., King, J.N., Jeunesse, E.C., Lees, P. & Toutain, P.L. (2009b) Use of a pharmacokinetic/pharmacodynamic approach in the cat to determine a dosage regimen for the COX-2 selective drug robenacoxib. Journal of Veterinary Pharmacology and Therapeutics, 32, 18-30.
14. Hazewinkel, H.A., Van den Brom, W.E., Theyse, L.F., Pollmeier, M. & Hanson, P.D. (2003) Reduced dosage of ketoprofen for the short-term and long-term treatment of joint pain in dogs. The Veterinary Record, 152, 11-14.
15. Hazewinkel, H.A., Van den Brom, W.E., Theyse, L.F., Pollmeier, M. & Hanson, P.D. (2008) Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. Research in Veterinary Science, 84, 74-79.
16. Higgs, G.A., Harvey, E.A., Ferreira, S.H. & Vane, J.R. (1976) The effects of anti-inflammatory drugs on the production of prostaglandins in vivo. Advances in Prostaglandin and Thromboxane Research, 1, 105-110.
17. Higgs, G.A., Palmer, R.M.J., Eakins, K.E. & Moncada, S. (1981) Arachidonic acid metabolism as a source of inflammatory mediators and its inhibition as a mechanism of action for anti-inflammatory drugs. Molecular Aspects of Medicine, 4, 275-301.
18. Jung, M., Lees, P., Seewald, W. & King, J.N. (2009) Analytical determination and pharmacokinetics of robenacoxib in the dog. Journal of Veterinary Pharmacology and Therapeutics, 32, 41-48.
19. King, J.N., Dawson, J., Esser, R.E., Fujimoto, R., Kimble, E.F., Maniara, W., Marshall, P.J., O'Byrne, L., Quadros, E., Toutain, P.L. & Lees, P. (2009a) Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2. Journal of Veterinary Pharmacology and Therapeutics, 32, 1-17.
20. King, J.N., Rudaz, C., Borer, L., Jung, M., Seewald, W. & Lees, P. (2009b) Evaluation of robenacoxib as a cyclooxygenase inhibitor in the dog: a comparative study. Journal of Veterinary Pharmacology and Therapeutics, 32 (Suppl. 1), 222.
21. Landoni, M.F. & Lees, P. (1995) Comparison of the anti-inflammatory actions of flunixin and ketoprofen in horses applying PK/PD modelling. Equine Veterinary Journal, 27, 247-256.
22. Landoni, M.F., Cunningham, F.M. & Lees, P. (1995) Determination of pharmacokinetics and pharmacodynamics of flunixin in calves by use of pharmacokinetic/pharmacodynamic modelling. American Journal of Veterinary Research, 56, 786-793.
23. Lees, P., Landoni, M.F., Giraudel, J.M. & Toutain, P.L. (2004) Pharmacodynamics and pharmacokinetics of non-steroidal anti-inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology and Therapeutics, 27, 479-490.
24. Lipscomb, V.J., Aliabadi, F.S., Lees, P., Pead, M.J. & Muir, P. (2002) Clinical efficacy and pharmacokinetics of carprofen in the treatment of dogs with osteoarthritis. The Veterinary Record, 150, 684-689.
25. Masferrer, J.L., Zweifel, B.S., Manning, P.T., Hauser, S.D., Leahy, K.M., Smith, W.G., Isakson, P.C. & Seibert, K. (1994) Selective inhibition of inducible cyclooxygenase-2 in vivo is anti-inflammatory and nonulcerogenic. Proceedings of the National Academy of Sciences of the United States of America, 91, 3228-3232.
26. McCann, M.E., Andersen, D.R., Zhang, D., Brideau, C., Black, W.C., Hanson, P.D. & Hickey, G.J. (2004) In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. American Journal of Veterinary Research, 65, 503-512.
27. McCarty, D.J. & Faires, J.S. (1963) A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters - a bioassay technique. Current Therapeutic Research, Clinical and Experimental, 5, 284-290.
28. Millis, D.L., Weigel, J.P., Moyers, T. & Buonomo, F.C. (2002) Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs. Veterinary Therapeutics: research in applied veterinary medicine, 3, 453-464.
29. Okuda, K., Nakahama, H., Miyakawa, H. & Shima, K. (1984) Arthritis induced in cat by sodium urate: a possible animal model for tonic pain. Pain, 18, 287-297.
30. Pairet, M. & Engelhardt, G. (1996) Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundamental & Clinical Pharmacology, 10, 1-17.
31. Pairet, M. & Van Ryn, J. (1998) Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal anti-inflammatory drugs. Inflammation Research, 47 (Suppl. 2), S93-S101.
32. Patrignani, P., Panara, M.R., Greco, A., Fusco, O., Natoli, C., Iacobelli, S., Cipollone, F., Ganci, A., Créminon, C., Maclouf, J. & Patrono, C. (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. The Journal of Pharmacology and Experimental Therapeutics, 271, 1705-1712.
33. Renberg, W.C., Johnston, S.A., Carrig, C.B., Budsberg, S.C., Ye, K. & Veit, H.P. (2000) Evaluation of a method for experimental induction of osteoarthritis of the hip joints in dogs. American Journal of Veterinary Research, 61, 484-491.
34. Schnitzer, T., Burmester, G., Mysler, E., Hochberg, M., Doherty, M., Ehrsam, E., Gitton, X., Krammer, G., Mellein, B., Matchaba, P., Gimona, A., Hawkey, C. on behalf of the TARGET Study Group. (2004) Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) a randomised controlled trial of lumiracoxib vs naproxen and ibuprofen: reduction in ulcer complications. Lancet, 364, 665-667.
35. Sessions, J.K., Reynolds, L.R. & Budsberg, S.C. (2005) In vivo effects of carprofen, deracoxib and etodolac on prostanoid production in blood, gastric mucosa and synovial fluid in dogs with chronic osteoarthritis. American Journal of Veterinary Research, 66, 812-817.
36. Streppa, H.K., Jones, C.J. & Budsberg, S.C. (2002) Cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs in canine blood. American Journal of Veterinary Research, 63, 91-94.
37. Taylor, P.M., Delatour, P., Landoni, F.M., Deal, C., Pickett, C., Aliabadi, F.S. & Lees, P. (1996) Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. Research in Veterinary Science, 60, 144-151.
38. Toutain, P.L., Cester, C.C., Haak, T. & Metge, S. (2001a) Pharmacokinetic profile and in vitro selective cyclooxygenase-2 inhibition by nimesulide in the dog. Journal of Veterinary Pharmacology and Therapeutics, 24, 35-42.
39. Toutain, P.L., Cester, C.C., Haak, T. & Laroute, V. (2001b) A pharmacokinetic/pharmacodynamic approach vs. a dose titration for the determination of a dosage regimen: the case of nimesulide, a COX-2 selective nonsteroidal anti-inflammatory drug in the dog. Journal of Veterinary Pharmacology and Therapeutics, 24, 43-55.
40. Van Arman, C.G., Carlson, R.P., Risley, E.A., Thomas, R.H. & Nuss, G.W. (1970) Inhibitory effects of indomethacin, aspirin and certain other drugs on inflammations induced in rat and dog by carrageenan, sodium uric and ellagic acid. The Journal of Pharmacology and Experimental Therapeutics, 175, 459-468.
41. Wallace, M.S., Zawie, D.A. & Garvey, M.S. (1990) Gastric ulceration in the dog secondary to the use of nonsteroidal anti-inflammatory drugs. The Journal of the American Animal Hospital Association (USA), 26, 467-472.
42. Warner, T.D., Giuliano, F., Vojnovic, I., Bukasa, A., Mitchell, J.A. & Vane, J.R. (1999) Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences of the United States of America, 96, 7563-7568.
43. Watson, D.J., Harper, S.E., Zhao, P.L., Quan, H., Bolognese, J.A. & Simon, T.J. (2000) Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis. Archives of Internal Medicine, 160, 2998-3003.